Literature DB >> 21741082

Mannosyl-coated nanocomplexes from amphiphilic cyclodextrins and pDNA for site-specific gene delivery.

Alejandro Díaz-Moscoso1, Nicolas Guilloteau, Céline Bienvenu, Alejandro Méndez-Ardoy, José L Jiménez Blanco, Juan M Benito, Loïc Le Gourriérec, Christophe Di Giorgio, Pierre Vierling, Jacques Defaye, Carmen Ortiz Mellet, José M García Fernández.   

Abstract

Fully homogeneous facial amphiphiles consisting in a cyclodextrin (CD) platform onto which a polycationic cluster and a multi-tail hydrophobic moiety have been installed (polycationic amphiphilic CDs; paCDs) self-organized in the presence of plasmid DNA to form nanometric complexes (CDplexes) which exhibit broad-range transfection capabilities. We hypothesized that biorecognizable moieties located at the hydrophilic rim in the CD scaffold would be exposed at the surface of the corresponding nanoparticles after DNA-promoted aggregation, endowing the system with molecular recognition abilities towards cell receptors. This concept has been demonstrated by developing an efficient synthetic strategy for the preparation of multivalent polycationic glyco-amphiphilic CDs (pGaCDs). Self-assembled nanoparticles obtained from mannosylated pGaCDs and pDNA (average hydrodynamic diameter 80 nm) have been shown to be specifically recognized by mannose-specific lectins, including concanavalin A (Con A) and the human macrophage mannose receptor (MMR). Further macrophage adhesion studies indicated that unspecific binding, probably due to electrostatic interactions with negatively charged cell membrane components, can also operate. The relative specific versus non-specific internalization is dependent on the pGaCD:pDNA proportion, being optimal at a protonable nitrogen/phosphate (N/P) ratio of 5. The resulting GlycoCDplexes were shown to specifically mediate transfection in Raw 264.7 (murine macrophage) cells expressing the mannose-fucose receptor in vitro. FACS experiments confirmed that transfection using these nanoparticles is mannose-dependent, supporting the potential of the approach towards vectorized gene delivery.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21741082     DOI: 10.1016/j.biomaterials.2011.06.025

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  13 in total

1.  Cyclodextrin-based targeting strategies for tumor treatment.

Authors:  Juan-Juan Yin; Zhi-Wei Zhou; Shu-Feng Zhou
Journal:  Drug Deliv Transl Res       Date:  2013-08       Impact factor: 4.617

2.  Design and evaluation of thioalkylated mannose-modified dendrimer (G3)/α-cyclodextrin conjugates as antigen-presenting cell-selective siRNA carriers.

Authors:  Keiichi Motoyama; Ryosuke Mitsuyasu; Chiho Akao; Takahiro Tanaka; Ayumu Ohyama; Nana Sato; Taishi Higashi; Hidetoshi Arima
Journal:  AAPS J       Date:  2014-09-19       Impact factor: 4.009

Review 3.  Lipothioureas as Lipids for Gene Transfection: A Review.

Authors:  Marie Breton; Jeanne Leblond; Isabelle Tranchant; Daniel Scherman; Michel Bessodes; Jean Herscovici; Nathalie Mignet
Journal:  Pharmaceuticals (Basel)       Date:  2011-10-24

Review 4.  CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease.

Authors:  Mujeeb Ur Rahman; Muhammad Bilal; Junaid Ali Shah; Ajeet Kaushik; Pierre-Louis Teissedre; Małgorzata Kujawska
Journal:  Pharmaceutics       Date:  2022-06-13       Impact factor: 6.525

5.  In vitro investigations of the efficacy of cyclodextrin-siRNA complexes modified with lipid-PEG-Octaarginine: towards a formulation strategy for non-viral neuronal siRNA delivery.

Authors:  Aoife M O'Mahony; Stephane Desgranges; Julien Ogier; Aoife Quinlan; Marc Devocelle; Raphael Darcy; John F Cryan; Caitriona M O'Driscoll
Journal:  Pharm Res       Date:  2012-11-29       Impact factor: 4.200

6.  Cationic and PEGylated Amphiphilic Cyclodextrins: Co-Formulation Opportunities for Neuronal Sirna Delivery.

Authors:  Aoife M O'Mahony; Julien Ogier; Raphael Darcy; John F Cryan; Caitriona M O'Driscoll
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

Review 7.  Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges.

Authors:  Monika Toporkiewicz; Justyna Meissner; Lucyna Matusewicz; Aleksander Czogalla; Aleksander F Sikorski
Journal:  Int J Nanomedicine       Date:  2015-02-17

Review 8.  Nano-Assemblies of Modified Cyclodextrins and Their Complexes with Guest Molecules: Incorporation in Nanostructured Membranes and Amphiphile Nanoarchitectonics Design.

Authors:  Leïla Zerkoune; Angelina Angelova; Sylviane Lesieur
Journal:  Nanomaterials (Basel)       Date:  2014-08-20       Impact factor: 5.076

Review 9.  Translational Advances of Hydrofection by Hydrodynamic Injection.

Authors:  Luis Sendra; María José Herrero; Salvador F Aliño
Journal:  Genes (Basel)       Date:  2018-03-01       Impact factor: 4.096

10.  Aggregation behaviour of amphiphilic cyclodextrins: the nucleation stage by atomistic molecular dynamics simulations.

Authors:  Giuseppina Raffaini; Antonino Mazzaglia; Fabio Ganazzoli
Journal:  Beilstein J Org Chem       Date:  2015-12-07       Impact factor: 2.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.